Q2 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$334M+75.2% YoY

Gross Profit

$50M15.1% margin

Operating Income

$28M8.3% margin

Net Income

$3M0.9% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

+5.9%

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

-$601,000

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.7B

Stockholders' Equity

$197M

Cash & Equivalents

$141M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$334M	$191M	+75.2%
Gross Profit	$50M	-$4M	+1479.0%
Operating Income	$28M	$179,000	+15362.6%
Net Income	$3M	-$11M	+127.1%

Revenue Segments

Health Care, Patient Service

$295M47%

Commercial Insurance1

$187M30%

Medicare1

$71M11%

Capitation Arrangements

$38M6%

Workers' Compensation/Personal Injury1

$11M2%

Medicaid1

$9M1%

Health Care, Management Service

$6M1%

Health Care, Patient Service Other

$5M1%

Health Care, Other

$4M1%

Teleradiology and Software

$3M0%